Bloomin' Brands Director Melanie Marein‑Efron Receives RSUs, Exercises Options

What Happened

• Melanie Marein‑Efron, a director of Bloomin' Brands (BLMN), had three related transactions reported for 2026-04-22: conversion/exercise of 19,746 derivative units into shares (acquired), a grant/award of 23,485 restricted stock units (RSUs) (acquired, derivative), and disposition of 19,746 shares (disposed).
• All transactions show a reported price of $0.00 because these were RSU vesting/conversion events (no cash exercise price). The filing does not list cash values for the disposed shares in the excerpt provided.

Key Details

• Transaction date: 2026-04-22; Form 4 filed 2026-04-24 (timely).
• Reported amounts: 23,485 RSUs granted (will fully vest prior to the 2027 annual meeting — F2); 19,746 RSUs fully vested and were converted prior to the 2026 annual meeting (F4) and those 19,746 shares were disposed per the filing.
• Price: $0.00 reported for these derivative/vesting conversions (typical for RSU settlement) — see F1 explaining an RSU equals the contingent right to one share on vesting.
• Shares owned after the transactions: not specified in the provided excerpt.
• No indication of a 10b5‑1 plan, tax‑withholding sale code, or late filing in the information supplied.

Context

• These entries reflect RSU vesting and settlement rather than an open‑market purchase. The 19,746 units that vested were converted to shares and then disposed as reported; the newly granted 23,485 RSUs remain derivative awards that will vest before the 2027 annual meeting.
• For retail investors, grants/vests are routine executive compensation events and do not by themselves indicate a buy or sell opinion; the disposal of vested shares is common for tax withholding or portfolio management.